nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—appendage—germ cell cancer	0.0186	0.176	CbGeAlD
Paricalcitol—VDR—skin epidermis—germ cell cancer	0.0155	0.146	CbGeAlD
Paricalcitol—VDR—neck—germ cell cancer	0.0074	0.07	CbGeAlD
Paricalcitol—CYP3A4—urine—germ cell cancer	0.00638	0.0603	CbGeAlD
Paricalcitol—UGT1A4—endocrine gland—germ cell cancer	0.00575	0.0543	CbGeAlD
Paricalcitol—CYP24A1—endocrine gland—germ cell cancer	0.00575	0.0543	CbGeAlD
Paricalcitol—VDR—eye—germ cell cancer	0.0055	0.052	CbGeAlD
Paricalcitol—VDR—skin of body—germ cell cancer	0.00479	0.0453	CbGeAlD
Paricalcitol—VDR—decidua—germ cell cancer	0.00476	0.045	CbGeAlD
Paricalcitol—VDR—uterus—germ cell cancer	0.00416	0.0393	CbGeAlD
Paricalcitol—VDR—pituitary gland—germ cell cancer	0.00409	0.0386	CbGeAlD
Paricalcitol—VDR—adrenal gland—germ cell cancer	0.00365	0.0345	CbGeAlD
Paricalcitol—VDR—bone marrow—germ cell cancer	0.00353	0.0334	CbGeAlD
Paricalcitol—VDR—female gonad—germ cell cancer	0.0034	0.0322	CbGeAlD
Paricalcitol—VDR—endocrine gland—germ cell cancer	0.00317	0.0299	CbGeAlD
Paricalcitol—VDR—head—germ cell cancer	0.00312	0.0295	CbGeAlD
Paricalcitol—VDR—testis—germ cell cancer	0.00302	0.0285	CbGeAlD
Paricalcitol—Lymphadenopathy—Methotrexate—germ cell cancer	0.00223	0.0025	CcSEcCtD
Paricalcitol—Cardiac disorder—Cisplatin—germ cell cancer	0.00223	0.00249	CcSEcCtD
Paricalcitol—Agitation—Ifosfamide—germ cell cancer	0.00223	0.00249	CcSEcCtD
Paricalcitol—Discomfort—Dactinomycin—germ cell cancer	0.00223	0.00249	CcSEcCtD
Paricalcitol—Angioedema—Ifosfamide—germ cell cancer	0.00222	0.00248	CcSEcCtD
Paricalcitol—Anorexia—Bleomycin—germ cell cancer	0.00221	0.00247	CcSEcCtD
Paricalcitol—Hypoaesthesia—Etoposide—germ cell cancer	0.00219	0.00245	CcSEcCtD
Paricalcitol—VDR—lymph node—germ cell cancer	0.00219	0.0207	CbGeAlD
Paricalcitol—Malaise—Ifosfamide—germ cell cancer	0.00219	0.00244	CcSEcCtD
Paricalcitol—Vertigo—Ifosfamide—germ cell cancer	0.00218	0.00244	CcSEcCtD
Paricalcitol—Urinary tract disorder—Etoposide—germ cell cancer	0.00217	0.00243	CcSEcCtD
Paricalcitol—Leukopenia—Ifosfamide—germ cell cancer	0.00217	0.00243	CcSEcCtD
Paricalcitol—Immune system disorder—Cisplatin—germ cell cancer	0.00217	0.00243	CcSEcCtD
Paricalcitol—Abdominal pain—Vinblastine—germ cell cancer	0.00217	0.00242	CcSEcCtD
Paricalcitol—Mediastinal disorder—Cisplatin—germ cell cancer	0.00216	0.00242	CcSEcCtD
Paricalcitol—Hypotension—Bleomycin—germ cell cancer	0.00216	0.00242	CcSEcCtD
Paricalcitol—Oedema—Dactinomycin—germ cell cancer	0.00216	0.00241	CcSEcCtD
Paricalcitol—Urethral disorder—Etoposide—germ cell cancer	0.00216	0.00241	CcSEcCtD
Paricalcitol—Infection—Dactinomycin—germ cell cancer	0.00214	0.0024	CcSEcCtD
Paricalcitol—Arrhythmia—Cisplatin—germ cell cancer	0.00214	0.0024	CcSEcCtD
Paricalcitol—Palpitations—Ifosfamide—germ cell cancer	0.00214	0.0024	CcSEcCtD
Paricalcitol—Alopecia—Cisplatin—germ cell cancer	0.00212	0.00237	CcSEcCtD
Paricalcitol—Cough—Ifosfamide—germ cell cancer	0.00212	0.00237	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00211	0.00236	CcSEcCtD
Paricalcitol—Hypertension—Ifosfamide—germ cell cancer	0.00209	0.00234	CcSEcCtD
Paricalcitol—Malnutrition—Cisplatin—germ cell cancer	0.00209	0.00234	CcSEcCtD
Paricalcitol—Paraesthesia—Bleomycin—germ cell cancer	0.00208	0.00232	CcSEcCtD
Paricalcitol—Dyspnoea—Bleomycin—germ cell cancer	0.00206	0.00231	CcSEcCtD
Paricalcitol—Chest pain—Ifosfamide—germ cell cancer	0.00206	0.00231	CcSEcCtD
Paricalcitol—Myalgia—Ifosfamide—germ cell cancer	0.00206	0.00231	CcSEcCtD
Paricalcitol—Arthralgia—Ifosfamide—germ cell cancer	0.00206	0.00231	CcSEcCtD
Paricalcitol—Anorexia—Dactinomycin—germ cell cancer	0.00206	0.0023	CcSEcCtD
Paricalcitol—Eye disorder—Etoposide—germ cell cancer	0.00206	0.0023	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00205	0.00229	CcSEcCtD
Paricalcitol—Cardiac disorder—Etoposide—germ cell cancer	0.00204	0.00228	CcSEcCtD
Paricalcitol—Discomfort—Ifosfamide—germ cell cancer	0.00204	0.00228	CcSEcCtD
Paricalcitol—Hypersensitivity—Vinblastine—germ cell cancer	0.00202	0.00226	CcSEcCtD
Paricalcitol—Decreased appetite—Bleomycin—germ cell cancer	0.00201	0.00225	CcSEcCtD
Paricalcitol—Muscle spasms—Cisplatin—germ cell cancer	0.00201	0.00225	CcSEcCtD
Paricalcitol—Angiopathy—Etoposide—germ cell cancer	0.002	0.00223	CcSEcCtD
Paricalcitol—Confusional state—Ifosfamide—germ cell cancer	0.00199	0.00223	CcSEcCtD
Paricalcitol—Immune system disorder—Etoposide—germ cell cancer	0.00199	0.00222	CcSEcCtD
Paricalcitol—Mediastinal disorder—Etoposide—germ cell cancer	0.00198	0.00222	CcSEcCtD
Paricalcitol—Pain—Bleomycin—germ cell cancer	0.00198	0.00221	CcSEcCtD
Paricalcitol—Oedema—Ifosfamide—germ cell cancer	0.00198	0.00221	CcSEcCtD
Paricalcitol—Chills—Etoposide—germ cell cancer	0.00197	0.00221	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00197	0.0022	CcSEcCtD
Paricalcitol—Asthenia—Vinblastine—germ cell cancer	0.00197	0.0022	CcSEcCtD
Paricalcitol—Infection—Ifosfamide—germ cell cancer	0.00197	0.0022	CcSEcCtD
Paricalcitol—Alopecia—Etoposide—germ cell cancer	0.00194	0.00217	CcSEcCtD
Paricalcitol—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00194	0.00217	CcSEcCtD
Paricalcitol—Nervous system disorder—Ifosfamide—germ cell cancer	0.00194	0.00217	CcSEcCtD
Paricalcitol—Ill-defined disorder—Cisplatin—germ cell cancer	0.00194	0.00217	CcSEcCtD
Paricalcitol—Anaemia—Cisplatin—germ cell cancer	0.00193	0.00216	CcSEcCtD
Paricalcitol—Skin disorder—Ifosfamide—germ cell cancer	0.00192	0.00215	CcSEcCtD
Paricalcitol—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00191	0.00214	CcSEcCtD
Paricalcitol—Feeling abnormal—Bleomycin—germ cell cancer	0.00191	0.00213	CcSEcCtD
Paricalcitol—Osteoarthritis—Methotrexate—germ cell cancer	0.0019	0.00213	CcSEcCtD
Paricalcitol—Anorexia—Ifosfamide—germ cell cancer	0.00189	0.00211	CcSEcCtD
Paricalcitol—Malaise—Cisplatin—germ cell cancer	0.00188	0.00211	CcSEcCtD
Paricalcitol—Decreased appetite—Dactinomycin—germ cell cancer	0.00188	0.0021	CcSEcCtD
Paricalcitol—Diarrhoea—Vinblastine—germ cell cancer	0.00188	0.0021	CcSEcCtD
Paricalcitol—Dysgeusia—Etoposide—germ cell cancer	0.00188	0.0021	CcSEcCtD
Paricalcitol—Leukopenia—Cisplatin—germ cell cancer	0.00187	0.00209	CcSEcCtD
Paricalcitol—Fatigue—Dactinomycin—germ cell cancer	0.00186	0.00208	CcSEcCtD
Paricalcitol—Back pain—Etoposide—germ cell cancer	0.00185	0.00207	CcSEcCtD
Paricalcitol—Hypotension—Ifosfamide—germ cell cancer	0.00185	0.00207	CcSEcCtD
Paricalcitol—Pain—Dactinomycin—germ cell cancer	0.00185	0.00206	CcSEcCtD
Paricalcitol—Muscle spasms—Etoposide—germ cell cancer	0.00184	0.00206	CcSEcCtD
Paricalcitol—Urticaria—Bleomycin—germ cell cancer	0.00184	0.00206	CcSEcCtD
Paricalcitol—Body temperature increased—Bleomycin—germ cell cancer	0.00183	0.00205	CcSEcCtD
Paricalcitol—Dizziness—Vinblastine—germ cell cancer	0.00181	0.00203	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.0018	0.00202	CcSEcCtD
Paricalcitol—Myalgia—Cisplatin—germ cell cancer	0.00178	0.00199	CcSEcCtD
Paricalcitol—Feeling abnormal—Dactinomycin—germ cell cancer	0.00178	0.00199	CcSEcCtD
Paricalcitol—Paraesthesia—Ifosfamide—germ cell cancer	0.00178	0.00199	CcSEcCtD
Paricalcitol—Ill-defined disorder—Etoposide—germ cell cancer	0.00178	0.00199	CcSEcCtD
Paricalcitol—Anxiety—Cisplatin—germ cell cancer	0.00177	0.00198	CcSEcCtD
Paricalcitol—Anaemia—Etoposide—germ cell cancer	0.00177	0.00198	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00177	0.00198	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00177	0.00197	CcSEcCtD
Paricalcitol—Dyspnoea—Ifosfamide—germ cell cancer	0.00176	0.00197	CcSEcCtD
Paricalcitol—Somnolence—Ifosfamide—germ cell cancer	0.00176	0.00197	CcSEcCtD
Paricalcitol—Discomfort—Cisplatin—germ cell cancer	0.00176	0.00197	CcSEcCtD
Paricalcitol—Vomiting—Vinblastine—germ cell cancer	0.00174	0.00195	CcSEcCtD
Paricalcitol—Malaise—Etoposide—germ cell cancer	0.00173	0.00193	CcSEcCtD
Paricalcitol—Breast disorder—Methotrexate—germ cell cancer	0.00172	0.00192	CcSEcCtD
Paricalcitol—Vertigo—Etoposide—germ cell cancer	0.00172	0.00192	CcSEcCtD
Paricalcitol—Decreased appetite—Ifosfamide—germ cell cancer	0.00172	0.00192	CcSEcCtD
Paricalcitol—Headache—Vinblastine—germ cell cancer	0.00172	0.00192	CcSEcCtD
Paricalcitol—Leukopenia—Etoposide—germ cell cancer	0.00171	0.00192	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Abdominal pain—Dactinomycin—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Body temperature increased—Dactinomycin—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Fatigue—Ifosfamide—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Oedema—Cisplatin—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Hypersensitivity—Bleomycin—germ cell cancer	0.00171	0.00191	CcSEcCtD
Paricalcitol—Infection—Cisplatin—germ cell cancer	0.00169	0.0019	CcSEcCtD
Paricalcitol—Pain—Ifosfamide—germ cell cancer	0.00169	0.00189	CcSEcCtD
Paricalcitol—Constipation—Ifosfamide—germ cell cancer	0.00169	0.00189	CcSEcCtD
Paricalcitol—Loss of consciousness—Etoposide—germ cell cancer	0.00168	0.00188	CcSEcCtD
Paricalcitol—Nervous system disorder—Cisplatin—germ cell cancer	0.00167	0.00187	CcSEcCtD
Paricalcitol—Cough—Etoposide—germ cell cancer	0.00167	0.00187	CcSEcCtD
Paricalcitol—Asthenia—Bleomycin—germ cell cancer	0.00166	0.00186	CcSEcCtD
Paricalcitol—Skin disorder—Cisplatin—germ cell cancer	0.00166	0.00185	CcSEcCtD
Paricalcitol—Hypertension—Etoposide—germ cell cancer	0.00165	0.00185	CcSEcCtD
Paricalcitol—Hyperhidrosis—Cisplatin—germ cell cancer	0.00165	0.00184	CcSEcCtD
Paricalcitol—Asthma—Methotrexate—germ cell cancer	0.00165	0.00184	CcSEcCtD
Paricalcitol—Pruritus—Bleomycin—germ cell cancer	0.00164	0.00183	CcSEcCtD
Paricalcitol—Feeling abnormal—Ifosfamide—germ cell cancer	0.00163	0.00182	CcSEcCtD
Paricalcitol—Chest pain—Etoposide—germ cell cancer	0.00163	0.00182	CcSEcCtD
Paricalcitol—Nausea—Vinblastine—germ cell cancer	0.00163	0.00182	CcSEcCtD
Paricalcitol—Anorexia—Cisplatin—germ cell cancer	0.00163	0.00182	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00162	0.00181	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00162	0.00181	CcSEcCtD
Paricalcitol—Pancreatitis—Methotrexate—germ cell cancer	0.00161	0.0018	CcSEcCtD
Paricalcitol—Discomfort—Etoposide—germ cell cancer	0.00161	0.0018	CcSEcCtD
Paricalcitol—Hypotension—Cisplatin—germ cell cancer	0.00159	0.00178	CcSEcCtD
Paricalcitol—Hypersensitivity—Dactinomycin—germ cell cancer	0.00159	0.00178	CcSEcCtD
Paricalcitol—Abdominal discomfort—Methotrexate—germ cell cancer	0.00158	0.00176	CcSEcCtD
Paricalcitol—Confusional state—Etoposide—germ cell cancer	0.00158	0.00176	CcSEcCtD
Paricalcitol—Urticaria—Ifosfamide—germ cell cancer	0.00157	0.00176	CcSEcCtD
Paricalcitol—Body temperature increased—Ifosfamide—germ cell cancer	0.00156	0.00175	CcSEcCtD
Paricalcitol—Abdominal pain—Ifosfamide—germ cell cancer	0.00156	0.00175	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00155	0.00174	CcSEcCtD
Paricalcitol—Infection—Etoposide—germ cell cancer	0.00155	0.00174	CcSEcCtD
Paricalcitol—Asthenia—Dactinomycin—germ cell cancer	0.00155	0.00173	CcSEcCtD
Paricalcitol—Paraesthesia—Cisplatin—germ cell cancer	0.00153	0.00171	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00153	0.00171	CcSEcCtD
Paricalcitol—Dyspnoea—Cisplatin—germ cell cancer	0.00152	0.0017	CcSEcCtD
Paricalcitol—Skin disorder—Etoposide—germ cell cancer	0.00152	0.0017	CcSEcCtD
Paricalcitol—Erectile dysfunction—Methotrexate—germ cell cancer	0.00152	0.0017	CcSEcCtD
Paricalcitol—Hyperhidrosis—Etoposide—germ cell cancer	0.00151	0.00169	CcSEcCtD
Paricalcitol—Anorexia—Etoposide—germ cell cancer	0.00149	0.00167	CcSEcCtD
Paricalcitol—Decreased appetite—Cisplatin—germ cell cancer	0.00148	0.00166	CcSEcCtD
Paricalcitol—Diarrhoea—Dactinomycin—germ cell cancer	0.00148	0.00165	CcSEcCtD
Paricalcitol—Pneumonia—Methotrexate—germ cell cancer	0.00148	0.00165	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00147	0.00165	CcSEcCtD
Paricalcitol—Vomiting—Bleomycin—germ cell cancer	0.00147	0.00165	CcSEcCtD
Paricalcitol—Infestation NOS—Methotrexate—germ cell cancer	0.00147	0.00164	CcSEcCtD
Paricalcitol—Infestation—Methotrexate—germ cell cancer	0.00147	0.00164	CcSEcCtD
Paricalcitol—Depression—Methotrexate—germ cell cancer	0.00146	0.00164	CcSEcCtD
Paricalcitol—Hypotension—Etoposide—germ cell cancer	0.00146	0.00163	CcSEcCtD
Paricalcitol—Rash—Bleomycin—germ cell cancer	0.00146	0.00163	CcSEcCtD
Paricalcitol—Pain—Cisplatin—germ cell cancer	0.00146	0.00163	CcSEcCtD
Paricalcitol—Dermatitis—Bleomycin—germ cell cancer	0.00146	0.00163	CcSEcCtD
Paricalcitol—Hypersensitivity—Ifosfamide—germ cell cancer	0.00146	0.00163	CcSEcCtD
Paricalcitol—Conjunctivitis—Methotrexate—germ cell cancer	0.00143	0.0016	CcSEcCtD
Paricalcitol—Asthenia—Ifosfamide—germ cell cancer	0.00142	0.00159	CcSEcCtD
Paricalcitol—Sweating—Methotrexate—germ cell cancer	0.00141	0.00157	CcSEcCtD
Paricalcitol—Feeling abnormal—Cisplatin—germ cell cancer	0.00141	0.00157	CcSEcCtD
Paricalcitol—Paraesthesia—Etoposide—germ cell cancer	0.0014	0.00157	CcSEcCtD
Paricalcitol—Pruritus—Ifosfamide—germ cell cancer	0.0014	0.00157	CcSEcCtD
Paricalcitol—Dyspnoea—Etoposide—germ cell cancer	0.00139	0.00156	CcSEcCtD
Paricalcitol—Somnolence—Etoposide—germ cell cancer	0.00139	0.00155	CcSEcCtD
Paricalcitol—Epistaxis—Methotrexate—germ cell cancer	0.00138	0.00155	CcSEcCtD
Paricalcitol—Nausea—Bleomycin—germ cell cancer	0.00138	0.00154	CcSEcCtD
Paricalcitol—Vomiting—Dactinomycin—germ cell cancer	0.00137	0.00154	CcSEcCtD
Paricalcitol—Rash—Dactinomycin—germ cell cancer	0.00136	0.00152	CcSEcCtD
Paricalcitol—Decreased appetite—Etoposide—germ cell cancer	0.00136	0.00152	CcSEcCtD
Paricalcitol—Diarrhoea—Ifosfamide—germ cell cancer	0.00135	0.00151	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00135	0.00151	CcSEcCtD
Paricalcitol—Body temperature increased—Cisplatin—germ cell cancer	0.00135	0.00151	CcSEcCtD
Paricalcitol—Fatigue—Etoposide—germ cell cancer	0.00135	0.00151	CcSEcCtD
Paricalcitol—Constipation—Etoposide—germ cell cancer	0.00134	0.00149	CcSEcCtD
Paricalcitol—Pain—Etoposide—germ cell cancer	0.00134	0.00149	CcSEcCtD
Paricalcitol—Dizziness—Ifosfamide—germ cell cancer	0.00131	0.00146	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—germ cell cancer	0.00131	0.00146	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—germ cell cancer	0.0013	0.00145	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—germ cell cancer	0.00129	0.00144	CcSEcCtD
Paricalcitol—Feeling abnormal—Etoposide—germ cell cancer	0.00129	0.00144	CcSEcCtD
Paricalcitol—Nausea—Dactinomycin—germ cell cancer	0.00128	0.00143	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Etoposide—germ cell cancer	0.00128	0.00143	CcSEcCtD
Paricalcitol—Vomiting—Ifosfamide—germ cell cancer	0.00126	0.00141	CcSEcCtD
Paricalcitol—Hypersensitivity—Cisplatin—germ cell cancer	0.00126	0.00141	CcSEcCtD
Paricalcitol—Rash—Ifosfamide—germ cell cancer	0.00125	0.0014	CcSEcCtD
Paricalcitol—Dermatitis—Ifosfamide—germ cell cancer	0.00125	0.00139	CcSEcCtD
Paricalcitol—Urticaria—Etoposide—germ cell cancer	0.00124	0.00139	CcSEcCtD
Paricalcitol—Body temperature increased—Etoposide—germ cell cancer	0.00124	0.00138	CcSEcCtD
Paricalcitol—Abdominal pain—Etoposide—germ cell cancer	0.00124	0.00138	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—germ cell cancer	0.00123	0.00138	CcSEcCtD
Paricalcitol—Asthenia—Cisplatin—germ cell cancer	0.00122	0.00137	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—germ cell cancer	0.00122	0.00137	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—germ cell cancer	0.0012	0.00134	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—germ cell cancer	0.00119	0.00133	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—germ cell cancer	0.00119	0.00133	CcSEcCtD
Paricalcitol—Chills—Methotrexate—germ cell cancer	0.00118	0.00132	CcSEcCtD
Paricalcitol—Nausea—Ifosfamide—germ cell cancer	0.00118	0.00131	CcSEcCtD
Paricalcitol—Diarrhoea—Cisplatin—germ cell cancer	0.00117	0.00131	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—germ cell cancer	0.00116	0.0013	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—germ cell cancer	0.00115	0.00129	CcSEcCtD
Paricalcitol—Hypersensitivity—Etoposide—germ cell cancer	0.00115	0.00129	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—germ cell cancer	0.00115	0.00128	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—germ cell cancer	0.00112	0.00126	CcSEcCtD
Paricalcitol—Asthenia—Etoposide—germ cell cancer	0.00112	0.00125	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—germ cell cancer	0.00111	0.00124	CcSEcCtD
Paricalcitol—Pruritus—Etoposide—germ cell cancer	0.00111	0.00124	CcSEcCtD
Paricalcitol—Vomiting—Cisplatin—germ cell cancer	0.00108	0.00121	CcSEcCtD
Paricalcitol—Rash—Cisplatin—germ cell cancer	0.00108	0.0012	CcSEcCtD
Paricalcitol—Dermatitis—Cisplatin—germ cell cancer	0.00107	0.0012	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—germ cell cancer	0.00107	0.0012	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—germ cell cancer	0.00106	0.00119	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—germ cell cancer	0.00106	0.00119	CcSEcCtD
Paricalcitol—CYP3A4—endocrine gland—germ cell cancer	0.00106	0.01	CbGeAlD
Paricalcitol—Malaise—Methotrexate—germ cell cancer	0.00103	0.00116	CcSEcCtD
Paricalcitol—Dizziness—Etoposide—germ cell cancer	0.00103	0.00116	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—germ cell cancer	0.00103	0.00115	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—germ cell cancer	0.00103	0.00115	CcSEcCtD
Paricalcitol—Nausea—Cisplatin—germ cell cancer	0.00101	0.00113	CcSEcCtD
Paricalcitol—Cough—Methotrexate—germ cell cancer	0.001	0.00112	CcSEcCtD
Paricalcitol—Vomiting—Etoposide—germ cell cancer	0.000994	0.00111	CcSEcCtD
Paricalcitol—Rash—Etoposide—germ cell cancer	0.000985	0.0011	CcSEcCtD
Paricalcitol—Dermatitis—Etoposide—germ cell cancer	0.000984	0.0011	CcSEcCtD
Paricalcitol—Headache—Etoposide—germ cell cancer	0.000979	0.00109	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—germ cell cancer	0.000976	0.00109	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—germ cell cancer	0.000976	0.00109	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—germ cell cancer	0.000976	0.00109	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00097	0.00108	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—germ cell cancer	0.000965	0.00108	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—germ cell cancer	0.000944	0.00106	CcSEcCtD
Paricalcitol—Infection—Methotrexate—germ cell cancer	0.00093	0.00104	CcSEcCtD
Paricalcitol—Nausea—Etoposide—germ cell cancer	0.000928	0.00104	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—germ cell cancer	0.000918	0.00103	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—germ cell cancer	0.000909	0.00102	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—germ cell cancer	0.000905	0.00101	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—germ cell cancer	0.000892	0.000998	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—germ cell cancer	0.000875	0.000978	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000853	0.000954	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—germ cell cancer	0.000847	0.000947	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—germ cell cancer	0.00084	0.00094	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—germ cell cancer	0.000834	0.000933	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—germ cell cancer	0.000832	0.000931	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—germ cell cancer	0.000824	0.000921	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—germ cell cancer	0.000814	0.00091	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000808	0.000904	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—germ cell cancer	0.000807	0.000902	CcSEcCtD
Paricalcitol—Pain—Methotrexate—germ cell cancer	0.0008	0.000895	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—germ cell cancer	0.000771	0.000863	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000765	0.000856	CcSEcCtD
Paricalcitol—Urticaria—Methotrexate—germ cell cancer	0.000744	0.000832	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—germ cell cancer	0.00074	0.000827	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—germ cell cancer	0.00074	0.000827	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—germ cell cancer	0.00069	0.000771	CcSEcCtD
Paricalcitol—Asthenia—Methotrexate—germ cell cancer	0.000672	0.000751	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—germ cell cancer	0.000662	0.000741	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—germ cell cancer	0.00064	0.000716	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—germ cell cancer	0.000619	0.000692	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—germ cell cancer	0.000595	0.000666	CcSEcCtD
Paricalcitol—Rash—Methotrexate—germ cell cancer	0.00059	0.00066	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—germ cell cancer	0.00059	0.000659	CcSEcCtD
Paricalcitol—Headache—Methotrexate—germ cell cancer	0.000586	0.000656	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—germ cell cancer	0.000556	0.000622	CcSEcCtD
